EcoR1 Capital, LLC, Director, 10% Owner at Zymeworks Inc. (ZYME), bought 180,470 shares at $11.60 ($2.1M) on 2025-04-01, disclosed to the SEC on 2025-04-02.
Open-market purchase of $2.1M ZYME by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.75 | 4,397 | $52K | 2.4% |
| 2 | $11.75 | 4,397 | $52K | 2.4% |
| 3 | $11.60 | 48,658 | $564K | 26.7% |
| 4 | $11.60 | 48,658 | $564K | 26.7% |
| 5 | $11.85 | 74,360 | $881K | 41.7% |
| Total | $11.71 avg | 180,470 |
| $2.1M |
| 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |